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Abstract
The innate immune response provides a critical defense against microbial infections, including viruses. These are recognised
by pattern recognition receptors including Toll-like receptors (TLRs) and RIG-I like helicases (RLHs). Detection of virus
triggers signalling cascades that induce transcription of type I interferons including IFNb, which are pivotal for the initiation
of an anti-viral state. Despite the essential role of IFNb in the anti-viral response, there is an incomplete understanding of the
negative regulation of IFNb induction. Here we provide evidence that expression of the Nemo-related protein, optineurin
(NRP/FIP2), has a role in the inhibition of virus-triggered IFNb induction. Over-expression of optineurin inhibited Sendai-
virus (SeV) and dsRNA triggered induction of IFNb, whereas depletion of optineurin with siRNA promoted virus-induced
IFNb production and decreased RNA virus replication. Immunoprecipitation and immunofluorescence studies identified
optineurin in a protein complex containing the antiviral protein kinase TBK1 and the ubiquitin ligase TRAF3. Furthermore,
mutagenesis studies determined that binding of ubiquitin was essential for both the correct sub-cellular localisation and the
inhibitory function of optineurin. This work identifies optineurin as a critical regulator of antiviral signalling and potential
target for future antiviral therapy.
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Introduction
The innate immune response is a highly conserved, first line of
defence against microbial pathogens including viruses. To be
activated the innate response identifies pathogen associated
molecular patterns (PAMPS) [1], which are detected by host
pattern recognition receptors (PRRs). The different classes of
PRRs implicated in the detection of virus include endosomal Toll-
like receptors (TLR), cytosolic DexD/H-box retinoic acid
inducible gene-I (RIG-I)-like helicases (RLH) and cytosolic DNA
receptors [2] [3] [4] [5,6,7]. Activation of PRRs results in the
production of pro-inflammatory cytokines and chemokines.
Central to this first line of defence are type I interferons (IFNa/
IFNb), which activate transcription of host genes and induce the
development of an anti-viral state in the host cell [8]. Loss of IFNb
signalling leads to severe immunodeficiency towards viral infection
[9]. All of the anti-viral PRRs can induce the transcription of
IFNb, although the signalling components vary between different
PRRs. Common features, however are the recruitment of adaptor
proteins (e.g. TLR3 recruits Toll-interleukin 1 receptor domain
containing adaptor inducing IFNb (TRIF)) to form a scaffold,
upon which cellular ubiquitin ligases including TRAF3, and the
protein kinases TANK-binding kinase 1 (TBK1) and its homo-
logue I-kB kinase (IKKe) are recruited [10].
TBK1/IKKe play a central role during the induction of IFNb in
response to virus infection, underscored by mouse knockout
experiments that demonstrate the loss of virus-triggered IFNb
production in TBK1 2/2 mice [11,12]. Currently, the molecular
mechanisms that regulate TBK1/IKKe activation are unclear,
although recent studies using the small cell permeant inhibitor
BX795 suggest that TBK1/IKKe are phosphorylated on Ser172 by
an undetermined protein kinase in response to TLR3 signalling
[13]. Phosphorylation of Ser172 leads to an activated form of the
kinase that is capable of phosphorylating down-stream substrates
including IRF3. Endogenous TBK1/IKKe is found complexed in
cells to a number of critical adaptor proteins including TANK [14],
NAP1 [15], SINTBAD [16] and the recently described optineurin
[17]. These adaptors bind constitutively to TBK1/IKKe and serve
to link the kinases to both upstream signalling components as well as
down-stream substrates [18] [19]. These studies suggest that there
are distinct TBK1/IKKe complexes within the cell that may
respond differently to anti-viral signalling [20].
Recently various proteins, including A20, SIKE and RNF125,
have been demonstrated to negatively regulate IFNb induction by
targeting TLR/RLH signalling pathways [21,22,23]. The TBK1
adaptor protein optineurin (also called NRP (Nemo related
protein) and FIP2 (14.7K-interacting protein 2)) inhibits TNFa
mediated activation of NFkB by competing with Nemo for binding
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to RIP1 and is implicated in TNFa induced cell death [24,25].
Here we describe optineurin as a negative regulator of virus-
induced IFNb induction. Optineurin achieves this via an ubiquitin-
dependent protein interaction with TBK1, with which it co-
localises within the cell. Over-expression of optineurin inhibits
IFNb expression, thereby increasing viral titres, whereas optineurin
siRNA dramatically enhances the IFN-mediated suppression of
virus replication. As such we propose that optineurin may
represent a broad ranging inhibitor of pro-inflammatory signalling.
Results
Expression of optineurin is induced in response to virus
infection
To investigate whether the expression of optineurin is activated in
response to viral infection, HEK293 cells were infected with the
RIG-I agonist Sendai virus (SeV) and HEK-TLR3 cells were treated
with the TLR3 ligand dsRNA (poly-I:C) (Figure 1). Using qPCR we
found that the abundance of optineurin RNA was increased after 6
hours of SeV infection or dsRNA treatment (Figure 1A). Consistent
with this we observed increased optineurin protein levels that
reached a peak after 12 hours (Figure 1B). Cells that were stimulated
with the mitogenic phorbol ester PMA (previously documented to
induce the expression of optineurin) [26] demonstrated similar levels
of optineurin induction (Figure 1A-B). To confirm that optineurin
protein synthesis was directly activated by virus infection and not
indirectly through a response to IFN, we repeated the SeV infections
in cells engineered to constitutively express a functional V protein of
Parainfluenza virus-5 (PIV5) that blocks IFN signaling (Hep2/PIV5-
V cells) (Figure S1A) [27,28] and in Vero cells, which lack the genes
for type I interferon [29]. Similar levels of optineurin protein
expression were observed in response to SeV infection or PMA
treatment in naı¨ve cells, PIV5-V expressing cells and Vero cells,
despite the inability of these cells to respond to IFN (Figures 1C and
S1B). These data collectively indicate that optineurin expression is
increased in direct response to virus infection.
Over-expression of optineurin inhibits TLR3 and
RLH-triggered induction of the IFNb promoter
Since optineurin levels are induced following viral infection we
next sought to determine whether optineurin regulates virus-
triggered signalling. Using reporter assays, over-expression of
optineurin strongly inhibited IFNb induction in response to SeV
infection in a dose-dependent manner (Figure 2A left). Furthermore,
over-expression of optineurin also inhibited dsRNA-induced
induction of the IFNb promoter in HEK-TLR3 expressing cells
(Figure 2A right). To further define the role of optineurin in the
RLH-triggered IFNb activation pathway, cells were transfected with
plasmids encoding RIG-I or Mda-5. Over-expression of RLHs
induced a robust activation of the IFNb reporter, as shown
previously [30,31]. Consistently, optineurin over-expression inhibit-
ed activation of the IFNb promoter in these assays (Figure S2A).
Importantly, the observed effects were not due to optineurin-
mediated effects on RIG-I or Mda-5 protein expression, as
demonstrated by western blotting (Figure S2A). Induction of IFNb
relies on the co-ordinated action of the transcription factors NFkB
and IRF3 [32,33,34]. In reporter assays optineurin inhibited SeV-
triggered activation of the NFkB-dependent PRDII element of the
IFNb promoter (Figure 2B), consistent with previous reports of an
optineurin-dependent inhibition of NFkB [24]. Importantly,
expression of optineurin inhibited SeV-induced activation of
PRDIII/I and ISRE (from the ISG54 gene) reporters, both
recognised by activated IRF3 (Figure 2B). In similar experiments
optineurin had no inhibitory effects on a serum response element
reporter (SRE) or a cAMP response element responsive reporter
(CRE) (Figure S2B). In comparison both reporters were successfully
inhibited in the presence of known viral antagonists of the MAPK
and cAMP pathways, NS5A and NS3, respectively [35,36,37].
Western blot analysis revealed that cells expressing optineurin
displayed a 60% reduction in IRF3 phosphorylation when infected
with SeV and a 50% decrease in IRF3 phosphorylation in
response to poly-I:C treatment (Figures 2C and S2C). Blotting
with phosphorylation state-independent antibodies showed similar
levels of total IRF3 (Figure 2C). These data imply that in cells
overexpressing optineurin the phosphorylation of IRF3 and its
subsequent activity are inhibited.
Consistent with the promoter reporter assays SeV-induced IFN-
b protein levels were also reduced in HEK293 cells over-
expressing optineurin (Figure 2D). Taken together, these data
indicate that optineurin acts specifically as a negative regulator of
the IFNb response to RNA-activated antiviral signalling pathways.
Sub cellular localisation of endogenous optineurin
Previous studies have shown that optineurin associates with
myosin VI and Rab8 [38,39]. These proteins are involved in the
transport of vesicles and cargo recruitment. It was plausible that
optineurin might regulate innate immune signalling in the
endocytic pathway. We therefore investigated the localisation of
endogenous optineurin. Consistent with previous findings opti-
neurin was found to localise to a Golgi-associated compartment as
demonstrated by co-staining for TGN46 (Figure 3) [38]. However,
a distinct portion of optineurin localised to a broader cytoplasmic
region of the cell (Figure 3A), which did not significantly localise
with EEA1 or CD63, markers of early and late endosomes
respectively (Figure 3B and 3C). In addition, we saw no significant
co-localisation of optineurin with concanavalin A (ConA)
(Figure 3D), which suggests that optineurin is not localised to
the endoplasmic reticulum (ER). When optineurin was transiently
over-expressed compared to the endogenous distribution we
observed increased accumulation of optineurin in TGN46 positive
vesicles, suggesting that over-expressing the protein increases
optineurin translocation to this compartment (see below).
Optineurin interacts with TBK1
We screened likely optineurin-binding partners from the innate
anti-viral signalling pathways for an interaction with optineurin by
expressing GST-tagged versions of the bait proteins and a HA-
Author Summary
Viral infection stimulates the innate immune response to
produce various cytokines and chemokines to induce an
anti-viral state within the host. The best studied of these are
the type I interferons (IFNa/b), which are essential for an
effective anti-viral response. Our understanding of how IFNb
is regulated is not well understood. This study demonstrates
that the Nemo-related protein optineurin helps to regulate
the levels of IFNb in response to virus infection. We
expressed optineurin in cells and found that the cells failed
to express IFNb when infected with various RNA viruses.
Using biochemical experiments we showed that optineurin
interacts with the protein kinase TBK1 and the ubiquitin
ligase TRAF3. Furthermore, a mutation in optineurin that
prevents the interaction with the small protein modifier
ubiquitin (D474N) ablated the negative regulatory function
of optineurin. Our findings provide a first example of a role
for optineurin in anti-viral signalling and aid in our
understanding of the negative regulation of IFNb.
Optineurin Regulates Antiviral Signaling
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tagged optineurin. This successfully detected a constitutive
interaction with the protein kinase TBK1, occurring both in the
presence and absence of SeV infection (Figure 4A). These
experiments were repeated using dsRNA treatment of HEK293-
TLR3 cells to activate TLR3 signalling and a similar constitutive
interaction between TBK1 and optineurin was detected (data not
shown). We next immunoprecipitated endogenous optineurin
from a murine macrophage cell line stimulated with poly-I:C and
investigated whether it was capable of interacting with TBK1. The
optineurin precipitates contained detectable levels of constitutively
bound TBK1 (Figure 4B). Additionally, an anti-TBK1 antibody
successfully immunoprecipitated optineurin from the same lysates
(Figure 4C). In parallel experiments, a control immunoprecipita-
tion undertaken with a pre-immune antibody, failed to precipitate
significant levels of TBK1 or optineurin (Figure 4B and C).
To further assess the interaction of TBK1 and optineurin we
investigated their intracellular localisation in HEK293 cells in
response to SeV infection. We observed prior to stimulation the
majority of optineurin localised with TBK-1 and both the
binding and amount of optineurin-TBK-1 co-localisation did
not change following stimulation, consistent with a constitutive
interaction (Figure 4D). The majority of optineurin (,65%)
localised to TBK-1 positive compartments whilst a smaller
proportion of total TBK1 was optineurin-associated (Figure 4D).
Optineurin is found in a complex containing the
ubiquitin ligase TRAF3
TRAF3 is a critical signalling molecule for IFNb activation in
response to virus infection [40], and is a well established binding
Figure 1. Optineurin expression is induced by virus infection. (A) Serum starved cells were infected with 100 HA units of Sendai virus (SeV),
100 mg/ml poly-I:C or PMA treated (100 ng/ml) and RNA was isolated from cells at the times shown and optineurin mRNA levels determined by Q-
PCR. Results were corrected for expression of an 18S loading control and calculated relative to an un-stimulated control. Error bars represent the
SEM values of stimulations from three independent experiments. (B) Immunoblot of cell lysates 8 and 12 hours after SeV infection (100 HA units/
ml), poly-I:C treatment (100 mg/ml) or treatment with PMA (100 ng/ml) analysed with polyclonal anti-optineurin antisera or anti-GAPDH (loading
control). All data are representative of at least three independent experiments. (C) Immunoblot of Hep-2 or Hep2-PIV5-V cell lysates 8 and 12 hours
after SeV infection (100 HA units/ml) or treatment with PMA (100 ng/ml) analysed with a polyclonal anti-optineurin antisera or anti-GAPDH (loading
control).
doi:10.1371/journal.ppat.1000778.g001
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partner for the TBK1 adaptor protein TANK, residing in a
trimeric complex containing TBK1 [19] [41]. GST pull-down
experiments confirmed the interactions between TBK1 and
optineurin (Figure 5A lanes 5 and 8), TBK1 and TRAF3
(Figure 5A lanes 4 and 6), and importantly, an interaction was
observed between optineurin and TRAF3. This interaction was
maintained when TRAF3 or optineurin were fused to GST
(Figure 5A lanes 7 and 9) and was specific as GST alone failed to
interact with any of the HA-tagged binding partners (Figure 5A
lanes 1–3). Furthermore, all constructs expressed to approximately
equal levels as judged by western blot analysis of cell lysates
(Figure 5A lanes 10–18).
To gain a better insight into the nature of this potential protein
complex, cells were transfected with a FLAG-tagged optineurin
with or without HA-TBK1 and anti-FLAG immunoprecipitations
were performed, as described by Gatot et al. [41]. The
immunoprecipitations were released from the beads by incubating
them with a FLAG peptide, and the released material was
immunoprecipitated with antibodies to endogenous TRAF3,
followed by an anti-HA western blot analysis, which detected
the TBK1 (Figure 5B). These data demonstrate that a ternary
complex is formed in cells consisting of optineurin, TBK1 and
TRAF3.
The ubiquitin-binding domain of optineurin is required
for inhibition of IFNb induction
Optineurin was recently identified from a genetic screen as a
novel ubiquitin binding protein [42]. Sequence alignment with the
related proteins, Nemo and Abin 1–3 revealed that they share a
highly conserved DFxxER (Ubiquitin binding in Abin and Nemo
(UBAN)) motif that is necessary for ubiquitin binding [42,43]. To
verify the ubiquitin binding abilities of optineurin we created an
ubiquitin binding deficient optineurin (D474N) mutant (Figure 6A).
The wild type and D474N mutant optineurin were expressed in
Figure 2. Optineurin inhibits TLR and RLH induction of IFNb. (A) Effect of optineurin on an IFNb promoter driven luciferase reporter (pIFNb-
luc) construct. HEK293 or HEK-TLR3 cells were transfected with the IFNb promoter-driven reporter in the presence of increasing amounts of
optineurin expression vector and infected with SeV (100 HA units/ml) (left) or stimulated with extracellular poly-I:C (100 mg/ml) (right). Cells were
lysed after 16 hours treatment and analysed for levels of luciferase. (B) HEK293 cells were transfected with either the PRDII, PRDIII/I or ISRE (from
ISG54) reporter constructs in combination with optineurin or an empty expression plasmid and infected with SeV (100 HA units/ml). Cells were lysed
after 16 hours treatment and analysed for levels of luciferase. Data for all experiments are presented as fold luciferase from an un-stimulated control
lacking optineurin co-expression. Error bars are SEM from three independent experiments. (C) HEK293 cells stably expressing optineurin or an empty
plasmid control were infected with SeV (100 HA units/ml) and lysed after 8 hours infection. Lysates were analysed for P-IRF3 (Ser396), IRF3, and
optineurin by immunoblot. (D) HEK293/HEK-TLR3 cells expressing optineurin or empty plasmid control were infected with SeV (100 HA units/ml) or
treated with poly-I:C (100 mg/ml) for 24 hours and IFNb production was determined by ELISA. Error bars are SEM from three independent
experiments.
doi:10.1371/journal.ppat.1000778.g002
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HEK293T cells and immunoblotting used to verify equal
expression and integrity (Figure 6A bottom panels). Bacterial
expressed GST tetra-ubiquitin (tetra-Ub) was used to pull-down
the optineurin proteins described above from cell lysates. We
observed binding of wild-type optineurin to tetra-Ub but the
mutation within the UBAN motif reduced binding significantly
(Figure 6A).
We reasoned that the ubiquitin-binding motif of optineurin
might aid in the interaction with binding partners such as TBK1.
To address this issue, the interaction between optineurin and
TBK1 was further analysed in cells. Cell lines expressing a GST-
tagged TBK1 were co-transfected with FLAG-tagged wild type or
D474N optineurin and the TBK1 precipitated with glutathione-
agarose beads. GST-TBK1 co-precipitated with wild-type opti-
neurin, whereas GST alone did not (Figure 6B). Interestingly,
GST-TBK1 precipitated substantially less optineurin D474N
compared to wild-type protein (Figure 6B top panels), with no
apparent difference in wild-type and D474N protein expression
(Figure 6B bottom panels). These data suggest that the ubiquitin-
binding domain (UBAN) of optineurin may therefore be required
for the efficient interaction with TBK1.
When the sub-cellular distribution of the D474N mutant protein
was analysed we observed a dramatic redistribution into a
cytosolic-like staining pattern whilst the wild-type optineurin
clustered around TGN46 positive vesicles (Figure 7A). This
suggests that part of the requirement for optineurin to target to
these membranes is fulfilled by an interaction with ubiquitin.
Consistent with this we observed a high degree of co-localisation of
ubiquitin at these clustered sites of optineurin localisation (data not
shown). Additionally, endogenous TBK1 displayed co-localisation
with over-expressed wild-type optineurin to these large vesicles,
whilst the endogenous TBK1 distribution in D474N over-
expressing cells remained diffuse (Figure 7A lower panels).
To elucidate the requirement for ubiquitin binding and TBK1
co-localisation on the inhibition of IFNb we analysed the effect of
the optineurin ubiquitin binding deficient mutant (D474N) on
activation of IFNb. In these studies TRIF was expressed
ectopically in lieu of extracellular poly-I:C as a means to activate
TLR3 signalling. In these reporter assays the optineurin D474N
mutant was unable to inhibit the activation of the IFNb promoter
in response to TLR3 or RIG-I signalling (Figure 7B).
Depletion of optineurin enhances the induction of ifnb
To confirm that endogenous optineurin also repressed IFNb
signalling, optineurin specific siRNA oligonucleotides were
employed. Immunoblotting demonstrated that two independent
optineurin siRNA oligonucleotides (optn1 and optn2) successfully
reduced optineurin expression by at least 70% (Figure 8A top),
whilst a scrambled control had negligible effect (Figure 8A top).
None of the oligonucleotides had a significant effect on the levels of
Figure 3. Optineurin distributes to a TGN like cellular compartment. HEK293 cells were serum starved overnight and the following day fixed
with ice-cold methanol and permeabilised with 50% methanol/acetone. Optineurin was visualised via labelling with polyclonal rabbit anti-optineurin
antibodies followed by staining with antibodies against (A) TGN46, (B) CD63 and (C) EEA1 followed by labelling with Alexa-fluor 488 conjugated
secondary antibodies. Labelled ConA (Alexa-594) (D) was added to cells for 1 hour after optineurin labelling with Alexa fluor 488 anti-rabbit secondary
antibodies. The indicated images on the right side indicate a higher magnification of the boxed areas. Representative confocal images are shown.
Scale bar indicates 10 mM.
doi:10.1371/journal.ppat.1000778.g003
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the housekeeping protein GAPDH (Figure 8A bottom). As
expected levels of ifnb mRNA rose sharply in response to infection
with SeV or treatment with dsRNA (Figure 8B). Silencing of
optineurin had no effect on the basal levels of ifnb mRNA in un-
stimulated cells but enhanced the subsequent induction of ifnb
transcripts by SeV and dsRNA (Figure 8B), whereas the scrambled
control oligonucleotide had no effect. Similarly, reporter gene
assays revealed that transcriptional activation of the IFNb
promoter in response to SeV and dsRNA was enhanced by
optineurin specific siRNA oligonucleotides but not the scrambled
control (Figure 8C). Parallel studies utilising the PRDII and ISRE
reporter constructs showed increased levels of NFkB and IRF3
driven transcription in optineurin silenced cells infected with SeV
(Figure S3). Consistent with the transcriptional data, SeV and
dsRNA induced IFN-b protein levels were also greater in the cells
transfected with optineurin specific siRNA oligonucleotides
(Figure 8D).
Optineurin regulates the response to virus infection
These studies were extended to measure the effects of optineurin
expression on replication of the alphavirus Semliki, Forest virus
(SFV), which is highly sensitive to type I interferons [44]. Cell lines
constitutively over-expressing optineurin were infected with a
recombinant SFV4 virus - SFV4(3H)-RLuc- carrying a Renilla
luciferase (RLuc) marker gene. In this virus, RLuc is flanked by
duplicated nsP2-protease cleavage sites at the nsP3/4 junction as
Figure 4. Optineurin interacts with TBK1. (A) HEK293T cells were transfected with HA-tagged optineurin in combination with GST or GST-TBK1.
Cells were incubated for 24 hours then infected with SeV (100 HA units/ml) for a further 8 hours before lysis. GST fusion proteins were precipitated from
lysates with glutathione-agarose beads and bound optineurin detected by immunoblot analysis. Precipitation of the appropriate GST protein was verified
by blotting the precipitates with anti-GST antisera. Expression of all proteins was verified by probing the lysates with anti-HA and anti-GST (+/2 denote
infection with SeV. PD and IB denote GST pulldown and immunoblot respectively). (B and C) Interaction of endogenous optineurin and TBK1 from
RAW264.7 cells. Cells were treated with poly-I:C (100 mg/ml) for the times indicated. Lysates were subjected to immunoprecipitation (IP) with anti-
optineurin, anti-TBK1 antibodies or pre-immune IgG coupled to protein G agarose. Immunoprecipitates were immunoblotted with the indicated
antibodies. Western blots of the lysates confirmed equal expression of the indicated proteins and an anti-GAPDH blot demonstrated equal loading of
protein. (D) Co-immunofluorescence of optineurin and TBK1 showing staining for endogenous optineurin (polyclonal antisera) and endogenous TBK1
(mouse monoclonal antibody). The images were merged to assess co-localisation and the images on the right side indicate a higher magnification of the
boxed areas. For quantification of co localization, images were captured as single optical sections of 50 mM thickness and analyzed using IMARIS software
using CoLoc and surpass modules. The number of co localized vesicles was expressed as a percentage of the total vesicle count for each of the 488 nm
and 594 nm channels using the surpass statistics tab. Each experiment represents the quantified co localization from 20 cells.
doi:10.1371/journal.ppat.1000778.g004
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part of the viral non-structural polyprotein [45,46]. Virus growth
curve assays were performed, and these clearly demonstrated that
cells over-expressing optineurin produced higher levels of Renilla
luciferase compared with those expressing empty plasmid
(compare white squares [control] to black squares [optineurin
over-expressing] Figure 9A). Additionally, SFV4(3H)-RLuc repli-
cation was measured in optineurin siRNA treated cells. Opti-
neurin siRNA treated cells were more resistant to SFV infection
and subsequently produced less luciferase than those treated with
the scrambled control siRNA (compare squares [control] to circles
[optineurin siRNA] Figure 9B).
As further verification of the role of optineurin in the anti-viral
response we analysed the effect of modulating the levels of
optineurin on the replication of Bunyamwera virus lacking the
IFN antagonist, NSs. Bunyamwera virus is a segmented negative
stranded RNA virus and the prototypic member of the Bunyaviridae
family. The NSs protein acts as a potent IFN antagonist and can
effectively block induction of IFNb [47]. Viruses lacking the NSs
protein (BUNdelNSs) are strong inducers of IFNb [47,48]. Cells
expressing wild-type optineurin or optineurin D474N along with
the IFNb reporter were infected with BUNdelNSs virus.
Figure 5. Optineurin is associated with TBK1 and TRAF3. (A)
HEK293T cells were transfected with combinations of GST, GST-TBK1,
GST-TRAF3 and GST-optineurin and vectors expressing HA-tagged
versions of these proteins. After 36 hours cells were lysed and GST
pulldowns performed (PD defines pulldown), followed by immunoblot-
ting with an anti-HA monoclonal antibody. (B) HEK293T cells were
transfected with a FLAG-optineurin and HA-TBK1 and lysates were
immunoprecipitated with FLAG-agarose beads. Precipitates were eluted
with a competing FLAG peptide, which was followed by immunoprecip-
itation with an anti-TRAF3 antibody. Precipitated samples were subjected
to immunoblot analysis with an anti-HA antibody to detect bound TBK1.
Lysates were also assessed for expression of the appropriate proteins.
doi:10.1371/journal.ppat.1000778.g005
Figure 6. Ubiquitin binding motif of optineurin is required for
TBK1 binding. (A) HEK293T cells were transfected with the indicated
optineurin plasmids and cell lysates were used for pulldown with
bacterial expressed GST or GST-tetraUb (PD denotes pulldown),
followed by immunoblotting with an anti-FLAG monoclonal antibody
to probe for bound optineurin. (B) HEK293T cells were transfected with
GST or GST-TBK1 plus the indicated optineurin plasmid. Cell lysates
were precipitated with glutathione agarose beads (PD denotes
pulldown). Precipitates were subjected to immunoblotting with
monoclonal anti-FLAG antibody to assess binding to optineurin and
anti-GST polyclonal antisera to confirm precipitation of the appropriate
GST fusion protein. Lysates were probed to demonstrate equal
expression of the expressed proteins.
doi:10.1371/journal.ppat.1000778.g006
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Optineurin had an inhibitory effect on IFNb reporter activation
after infection with BUNdelNSs, whereas the D474N mutant that
was incapable of binding to ubiquitin did not (Figure 9C).
Discussion
During infection cytokine signalling must be controlled to
prevent unwanted tissue damage. Host cells have therefore
developed strategies to regulate the level of cytokines produced
in response to infection. Critical to this regulation are an
increasing number of negative regulatory proteins. The results
presented in this paper establish optineurin as a novel regulator of
virus-triggered IFNb induction. Over-expression of optineurin
inhibited both TLR3 and cytoplasmic helicase (RIG-I/Mda-5)
triggered activation of the IFNb promoter and suppressed the
ability of a defective Bunyamweravirus to induce IFNb. Con-
versely, cells that were depleted of optineurin by treatment with
siRNA were more resistant to SeV and SFV infection, and these
cells produced more IFNb upon infection. Previously it has been
described that optineurin is induced by inflammatory cytokines
including TNFa [49]. We have now established that virus
infection also markedly increases the amount of optineurin protein
present in the cells directly as optineurin expression in cells unable
to respond to IFN was still up-regulated by virus infection.
Promoter mapping studies suggest this up-regulation is likely to be
mediated by NFkB [50]. Coupled with the observation that
optineurin deficiency did not result in induction of IFNb, but
rather augmented the virus-induced transcription of IFNb, these
data indicate that optineurin levels are increased upon virus
infection in order for it to contribute to the fine-tuning of the anti-
viral response.
Optineurin has recently been characterised as an NFkB-
regulated gene product that interacts with the receptor interacting
kinase RIP1 in response to TNFa and initiates a negative feedback
Figure 7. Ubiquitin binding motif of optineurin is required for function. (A) HEK293 cells were transfected with optineurin wildtype and
D474N and stained with anti-FLAG antibody to assess the sub-cellular distribution of optineurin. Additionally, cells were stained with markers for the
Golgi (TGN46) and endogenous TBK1. The images were merged to assess co-localisation and the images on the right side indicate a higher
magnification of the boxed areas. Representative confocal images are shown. Scale bar indicates 10 mM. (B) HEK293 cells were transfected with
pIFNb-luc, optineurin wild-type or D474N and either TRIF or Mda5. The next day cells were left untreated or were infected with 100HA units/ml of SeV
for 16 hours. Luciferase levels were determined and are presented as fold luciferase from an un-stimulated control lacking optineurin co-expression.
Error bars are SEM from three independent experiments.
doi:10.1371/journal.ppat.1000778.g007
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loop to inhibit NFkB signalling [24,50]. The inhibition of both
TNFa and IFNb pathways suggests that optineurin functions as a
negative feedback regulator of immune signalling. In this context it
Figure 8. Depletion of optineurin enhances the induction of
ifnb. (A) Optineurin levels were reduced by transfection of siRNA
oligonucleotides (optn1 and optn2) as demonstrated by immunoblot-
ting with polyclonal anti-optineurin antisera. The siRNA had minimal
impact on levels of GAPDH as judged by immunoblotting. (B) Cells
treated with optineurin siRNA or control siRNA were infected with 100
HA units/ml SeV or treated with extracellular poly-I:C (100 mg/ml) and
RNA was isolated from cells at the times shown and ifnb mRNA levels
determined by Q-PCR. Results were corrected for expression of 18S and
calculated relative to an un-stimulated control. Error bars represent the
SEM values of stimulations from three independent experiments. (C)
Levels of IFNb promoter driven luciferase were determined in
optineurin-silenced cells. Cells expressing IFNb-luc were stimulated as
described in (B) and levels of luciferase assayed. Results are shown as
fold luciferase from an un-stimulated control. (D) To detect levels of
IFNb protein cells were stimulated as described in (B) and (C) and
secreted cytokine was detected by ELISA. Error bars are SEM from three
independent experiments. Student’s t-test was used and for all tests, a P
value of less than 0.05 was considered statistically significant.
doi:10.1371/journal.ppat.1000778.g008
Figure 9. Optineurin regulates the response to virus infection.
(A) Cell lines expressing optineurin or empty expression plasmid were
infected (MOI 5) with recombinant SFV (SFV4(3H)-RLuc) containing a
Renilla luciferase (RLuc) reporter gene. Cells were lysed 8 hours post
infection and luciferase levels determined. Data is presented as fold
luciferase from uninfected control. Cells expressing optineurin (black
boxes), cells expressing empty plasmid (white boxes). (B) Cells treated
with optineurin siRNA optn1 and optn2 (black and white circles),
control siRNA (white box) or mock treated cells (black box) were
infected (MOI 5) with SFV4(3H)-RLuc. Cells were lysed 8 hours post
infection and luciferase levels determined. Data is presented as fold
luciferase from uninfected control. (C) Cells expressing optineurin
wildtype or D474N were infected with a Bunyamweravirus lacking the
IFN antagonist NSs protein in conjunction with the pIFNb-luc reporter
plasmid. Levels of viral induced IFNb-promoter driven luciferase were
assayed and are displayed as fold luciferase from an uninfected control.
Error bars are SEM from three independent experiments.
doi:10.1371/journal.ppat.1000778.g009
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will be important to determine the response of optineurin deficient
mice to virus infection.
To establish a molecular mechanism for the regulatory role of
optineurin we demonstrated an interaction with the protein kinase
TBK1. TBK1 is a ubiquitously expressed kinase and a critical
point of convergence for TLR and RLH-triggered induction of
IFNb, and as such is a likely candidate for regulation.
Characterisation of the optineurin-TBK1 interaction suggests that
optineurin is a TBK1 adaptor protein. Binding assays indicated
that optineurin was constitutively associated with TBK1, akin to
known adaptor proteins including TANK-NAP1-SINTBAD [20]
and immunofluorescence analysis demonstrated co-localisation of
optineurin and TBK1. Interestingly, quantification of the amounts
of optineurin co-localised with TBK1 revealed a significant pool of
TBK1 not associated with optineurin, which presumably con-
tained TBK1 complexed with other adaptor proteins (TANK-
NAP1-SINTBAD). Morton and colleagues recently identified
TBK1 as an optineurin binding partner [17]. Importantly, our
findings confirm the constitutive interaction data presented in their
study. Moreover, they also identified that optineurin and TANK
may share a common binding site on TBK1 [17], which supports
the theory that there are distinct pools of TBK1 within a cell, each
bound by a specific adaptor protein [20]. TBK1 is closely related
to IKKe and is thought to have overlapping functions, including
inducing transcription of type I IFN. Both TBK1 and IKKe
constitutively interact with TANK-NAP1-SINTBAD [20] and
these adaptor proteins are thought to be essential for the
overlapping functions of these kinases. Surprisingly, binding assays
demonstrated that optineurin was not able to interact with IKKe
[17]. If this were the case it suggests that optineurin is the first
TBK1 specific adaptor protein found to date and that the TBK1-
optineurin complex regulates distinct aspects of the response to
virus infection.
It is currently unclear exactly how optineurin regulates the
induction of IFNb. A clue comes from mutagenesis studies, which
demonstrate that the ubiquitin-binding motif (UBAN) within
optineurin is essential for inhibitory function, as a mutation within
this motif (D474N) profoundly impaired the ability of optineurin to
inhibit the induction of IFNb. Furthermore, our studies using this
mutant highlighted the requirement of this motif for binding to
TBK1. Although, the putative TBK1 binding motif within
optineurin has been suggested to locate to the amino terminal
third of the protein [17], our data clearly demonstrate that
significantly less optineurin (D474N) is bound by TBK1 compared
to wild-type protein. The disparity in findings prompted us to
investigate the effect of the D474N mutant on optineurin
localisation. Immunofluorescence analysis showed that the
D474N mutant was not targeted to the same sub-cellular
localisation as wild-type protein. Clearly, in this case the
ubiquitin-binding motif acts as a potent localisation signal.
Moreover, in co-localisation experiments the sites of specific
optineurin-TBK1 clustering were lost when optineurin was unable
to bind to ubiquitin. Collectively these data suggest that optineurin
targets TBK1 to specific sites in the cell and that this is dependent
on an interaction with ubiquitin. This was reminiscent of the role
of Eps15, which uses an ubiquitin-binding motif to correctly
orchestrate formation of protein complexes during receptor
tyrosine kinase endocytosis [51] and suggests a model where
optineurin may bind to specific ubiquitylated targets to orchestrate
specific signalling.
Recent studies suggest that key proteins within the antiviral
response are ubiquitylated; including RIG-I and IPS-1 [52,53] and
that several cellular regulators target this ubiquitylation including
CYLD, DUBA and RNF125 [23,54,55]. Indeed, a mechanism
proposed by Zhu and colleagues for the regulation of NFkB by
optineurin relies on the competitive recruitment of optineurin to
polyubiquitylated RIP1 [24]. The impact of the D474N mutant on
the ability of optineurin to inhibit IFNb induction would argue for
a similar mechanism in this case. A role for ubiquitin in the
function of optineurin is further strengthened by the observation
that optineurin can interact with TRAF3. We speculate that
TRAF3 may be required for the polyubiquitylation of optineurin
binding partners within the innate signalling pathways, although
these targets are not known at this stage. Further studies are
needed to ascertain the functional significance of the optineurin-
TBK1 sub-cellular targeting and the constituents of any multi-
protein complexes, in addition to TRAF3 that contain optineurin.
Future studies will undoubtedly identify additional ubiquitylated
binding partners for optineurin in antiviral signalling pathways.
In conclusion this study expands the role of optineurin, beyond
the negative regulation of TNFa signalling, to include the
regulation of virus triggered IFNb induction. Although, more
studies are needed to address the molecular mechanisms by which
optineurin regulates the antiviral response, we propose that that
optineurin may be a broad-spectrum negative regulator of
inflammation.
Materials and Methods
Materials
Poly-I:C and human embryonic kidney (HEK) cells expressing
TLR3 were purchased from Invivogen. Sendai virus (SeV) Cantell
strain was obtained from Charles River Laboratories. The
optineurin, TBK1, TRAF3 and HA antibodies were obtained
from Abcam. IRF3 and phospho-IRF3 (Ser 396) antibodies were
from Cell Signalling Technologies. Anti-FLAG monoclonal
antibody, FLAG peptide, protein G and Glutathione agarose
were from Sigma.
DNA manipulations
The luciferase reporter plasmids and Mda-5 expression vector
have been described previously [56] and were provided by S.
Goodbourn (University of London). The NS5A and NS3
expression vectors have been described previously [29][31]. The
plasmid for bacterial expressed GST-Ub was a kind gift from F.
Randow (University of Cambridge). An optineurin expression
construct was obtained from F. Buss (University of Cambridge)
and used as a template for PCR to generate an optineurin
sequence that was cloned into pEBG2T for expression as an
amino-terminal GST fusion or with an in-frame amino-terminal
FLAG or HA tag that were cloned into pcDNA3.1. A plasmid
expressing TRIF was a gift from L. O’Neill (Trinity College,
Dublin). RIG-I, TBK1, TRAF3 and IRF3 were amplified with
KOD polymerase and inserted into vectors for expression in
mammalian cells. Site directed mutagenesis of optineurin was
performed using a Quick-Change kit (Stratagene).
Cell culture, transfection and cell lysis
All cells lines were cultured in DMEM supplemented with 10%
fetal calf serum, 100 IU/ml penicillin, 100 ug/ml streptomycin
and 0.1% Normocin (Invivogen). Routine transfections were
carried out using PEI (Polysciences Inc.) at 5 mg/mg DNA
according to manufacturer’s instructions. Cells were lysed in lysis
buffer (50 mM Tris-HCl pH7.5, 1 mM EDTA, 1 mM EGTA, 1%
Triton-X100, 1 mM Na3VO4, 50 mM NaF, 5 mM sodium
pyrophosphate, 10 mM sodium glycerophosphate, 0.27 M sucrose
and 50 mM iodoacetamide) and placed on ice. Cell lysates were
clarified by centrifugation for 20 min at 18,000 g.
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GST pulldowns, immunoprecipitations and
immunoblotting
For GST pulldowns cells over-expressing the proteins of interest
were lysed in lysis buffer and either used immediately or snap
frozen in liquid nitrogen prior to storage at -80uC. 1 mg of total
cell lysate was incubated with glutathione-agarose beads for
4 hours at 4uC with constant shaking. For immunoprecipitations
involving over-expressed proteins in HEK293T cells, ectopically
expressed FLAG tagged protein was precipitated with FLAG-
agarose beads (Sigma) for 2 h at 4uC with constant shaking. For
precipitations of endogenous optineurin, RAW 264.7 and
HEK293 cells treated with poly-I:C (100 mg/ml) or infected with
SeV (100 HA units/ml) were lysed and 1 mg of total lysate was
incubated with 5 mg of anti-optineurin antibody for 2 h at 4uC and
then incubated with protein G agarose beads overnight. All
precipitates were washed thoroughly in lysis buffer, and proteins
released from the beads with the addition of Laemmli loading
buffer. Precipitated proteins were analysed by SDS PAGE,
transferred to PVDF membrane and immunoblotted. Levels of
phosphorylated IRF3 were quantified by Image densitometry
imaging to analyze intensity of western blot bands. The signal
intensities for quantification were normalized to the background
values and this signal subsequently normalized to the levels of total
IRF3.
Immunofluorescence
Cells grown on glass coverslips were transfected with either
FLAG-tagged optineurin (for over-expression studies) or the
indicated constructs (where applicable). 48 h post-seeding or
transfection, cells were fixed with ice-cold methanol for 10 min-
utes, followed by permeabilisation in ice-cold methanol/acetone
for 10 minutes. Cells were washed with PBS and blocked in PBS/1
% BSA for 30 min. Cells were then incubated with a rabbit
polyclonal anti-optineurin antibody (Abcam) for 1 h (for investi-
gation of endogenous localisation) or with mouse anti-FLAG
antibody (for over-expression studies) in PBS/1 % BSA and
washed with PBS prior to incubation with Alexa–Fluor 594
conjugated anti goat (rabbit) or anti-mouse secondary antibody
(Invitrogen-Molecular Probes) in PBS/1 % BSA for 1 hour at
room temperature. Cells were probed with sheep anti-TGN46
conjugated to anti-sheep 488 antibodies for Golgi investigation,
anti-mouse EEA1 or anti-CD63 antibodies conjugated to anti-
mouse secondaries for endosomal investigation. Cells were washed
and mounted onto microscope slides using Citifluor (Agar
Scientific). Labelled cells were viewed on a Zeiss 510-META laser
scanning confocal microscope under an oil-immersion 663
objective lens (NA=1.40). Alexa-fluor 594, (550 nm excitation:
570 nm emission) was excited using a helium/neon laser fitted
with 543 nm filters. Images displayed are representative and
displayed as single optical sections of 50 mM thickness.
For quantification of co localization, images were captured as
single optical sections of 50 mM thickness (maintaning identical
channel settings throughout) and analyzed using IMARIS software
using CoLoc and surpass modules. Briefly the thresholds of the
each channel were set at 10% of the maximum intensity and
vesicles of a diameter of 0.5 mMwere recorded in both the 488 nm
and 594 nm channels using Imaris to calculate the structures that
fall into this sizing. The number of vesicles was then entered into
the corresponding channel thresholds in the coLoc module and
white pixels appeared on the image to show the location of co-
localized pixels. The number of co localized vesicles was then
expressed as a percentage of the total vesicle count for each of the
488 nm and 594 nm channels using the surpass statistics tab. Each
experiment represents the quantified co localization from 20 cells.
Reporter assays
Cells (16105) were seeded into 12 well dishes and transfected
the following day using PEI (Polysciences Inc.) with reporter
plasmids expressing firefly luciferase under the control of the
complete IFNb promoter, the PRDII, PRDIII/I elements of the
IFNb promoter or a tandem ISRE element taken from the ISG54
promoter. Where appropriate, cells were co-transfected with
plasmids expressing cellular proteins (e.g. Mda5). Empty plasmid
was added to ensure each transfection received the same amount
of total DNA. To normalise for transfection efficiency pRLTK
Renilla luciferase reporter plasmid was added to each transfection.
Where necessary, 24 hours post transfection cells were treated with
100 mg/ml poly-I:C or infected with 100 HA units/ml Sendai
virus for a further 16 hours. Samples were lysed in passive lysis
buffer (Promega) and activity measured using a dual-luciferase
reporter assay system (Promega) as described [37].
SFV virus preparation and infection
Recombinant Renilla luciferase-expressing SFV4(3H)-RLuc (de-
rived from strain SFV4) [46] was grown in BHK-21 cells (37uC; in
MEM/2% newborn calf serum (NBCS). Virus-containing super-
natants were clarified by centrifugation (3x, 30 minutes,
15000 rpm) and viruses concentrated from supernatant on a
20% (w/v) sucrose/TNE buffer (pH 7.4) cushion by ultracentri-
fugation (25000 rpm, 90 minutes, SW28 rotor). Pellets were
resuspended in TNE buffer, and viruses titrated by plaque assay.
Infection of mammalian cells was performed at 37 uC for 1 hour,
respectively, at an m.o.i. of 5 plaque forming units (pfu) per cell in
DMEM containing 0.5% foetal calf serum. After infection
complete medium was added to the cells.
RNA interference
Decreased optineurin expression was obtained using pre-
validated siRNA molecules (Ambion). These were transfected
using the siPort Neofect reagent according to the protocol
provided by the manufacturer (Ambion).
Detection of cellular mRNA
Cells were transfected with siRNA to silence endogenous
optineurin as described. Cells were stimulated with agonist and
incubated for the times indicated. Total RNA was extracted using
a Nucleospin kit (Machery-Nagel) and cDNA was generated from
1 mg of total RNA using the Super-Script II reagent (BioRad). The
resulting cDNA was subjected to semi-quantitative real time PCR
using the SYBR green reagent (BioRad) as previously described
[57].
Determination of IFNb protein levels
HEK293 cells expressing optineurin or treated with optineurin
specific siRNA were infected with SeV (100 HA units/ml) or
treated with poly-I:C (100 mg/ml) and levels of secreted IFNb
detected by ELISA using the manufacturer’s protocols (PLB
Interferon Source).
Supporting Information
Figure S1 (A) HEp-2 parental and HEp-2 cells expressing the
PIV5 V protein (HEp-2/PIV5-V) cells were transfected with
luciferase reporter contructs pIFNb or pISRE and stimulated with
SeV infection or 1000 IU/ml IFNa. Expression of PIV5-V protein
had no significant effect on the levels of luciferase generated from
the pIFNb reporter, demonstrating that V is not able to inhibit the
production of IFN. In contrast expression of V led to a statistically
significant decrease in pISRE driven luciferase. These data show
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that cells expressing PIV5-V are able to produce IFN but not able
to respond to it. ** corresponds to a ,P0.05. (B) Vero cells were
serum starved for 24 hours then infected with SeV (100 HA units/
ml) or treated with PMA (100 ng/ml) for the indicated times. Cell
lysates were analysed with a polyclonal anti-optineurin antibody
and anti-GAPDH to show equal protein loading.
Found at: doi:10.1371/journal.ppat.1000778.s001 (0.50 MB TIF)
Figure S2 (A) Cells containing pIFNb-luc were co-transfected
with RIG-I (left) or Mda5 (right) expression plasmids in the
presence of increasing concentrations of optineurin expression
vector. (B) Cells were transfected with a serum responsive element
(SRE)-reporter (left) or (C) a cAMP responsive element (CRE)
reporter (right) in combination with optineurin or the appropriate
controls, HCV NS5A (left) and HCV NS3 (right). Cells were
stimulated with serum (SRE) or forskolin (CRE) (right) for 16
hours. Data for all experiments are presented as fold luciferase
from an unstimulated control lacking optineurin co-expression.
Error bars are SEM from three independent experiments. (D)
HEK293 cells stably expressing optineurin or an empty plasmid
control were infected with SeV (100 HA units/ml) and lysed after
8 hours infection. Lysates were analysed for P-IRF3 (Ser396),
IRF3, and optineurin by immunoblot.
Found at: doi:10.1371/journal.ppat.1000778.s002 (0.90 MB TIF)
Figure S3 Optineurin siRNA enhances PRDII and ISRE
activation. HEK293 expressing (A)PRDII or (B) ISRE reporter
constructs were treated with scrambled or optineurin specific
siRNA stimulated with SeV (100 HA Units/ml) for 18 hours and
levels of luciferase assayed. Results are shown as fold luciferase
from an unstimulated control. Error bars are SEM from three
independent experiments.
Found at: doi:10.1371/journal.ppat.1000778.s003 (0.33 MB TIF)
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